Men who take testosterone supplements for cardiovascular, sexual and physical function probably won’t see any benefits, researchers report. Researchers at Georgetown University collected data that sug...
Johnson & Johnson’s Janssen Pharmaceuticals knew about a faulty device and data in a Xarelto (rivaroxaban) regulatory trial that suggests they put participants at risk, The BMJ reports. Janssen withhe...
Patients who suffered trauma and received inferior vena cava (IVC) filters to prevent blood clots in the lungs had no survival advantage, researchers reported. The study published in JAMA Surgery show...
The U.S. Food and Drug Administration released a safety communication informing the public of stronger kidney injury warning labels on SGLT2 inhibitors that treat Type 2 diabetes, including J&J’s Invo...
The U.S. Food and Drug Administration warned that taking more than the recommended dose of the popular diarrhea medicine Imodium (loperamide) can cause severe heart problems and even lead to death. Ph...
A new medical study showed that patients who took opioid painkillers three months after hip replacement surgery were more likely to need revision surgery at one and five years than those who stopped t...
The U.S. Food and Drug Administration issued a Drug Safety Communication on May 18, 2016 warning that Type 2 diabetes medication Invokana (canagliflozin) could cause an increase in leg and foot amputa...
New research suggests that popular heartburn drugs called proton pump inhibitors (PPIs) such as Prevacid (lansoprazole), Prilosec (omeprazole) and Nexium (esomeprazole) may damage arteries leading to...
In the wake of two multi-million dollar jury verdicts, Johnson & Johnson faces another wave of lawsuits filed by women and surviving members of families who claim the company’s talcum powder caused ov...
A recent study published in the BMJ revealed Johnson & Johnson’s DePuy Pinnacle metal-on-metal hip implants have a high revision surgery rate because of manufacturing problems and high levels of metal...
